Articles
A case report: The first show phenomenon in the treatment of spinal cord injury with Regentime procedure using autologous bone marrow-derived stem cells
Abstract: This case report demonstrates “the first show phenomenon” following Regentime stem cell therapy applied to a spinal cord injury patient. A 40-year-old gentleman sustained a ballistic injury at the level of T9, resulting in complete bilateral motor and sensory loss from T9 and below. He ... >> Read Article
Degenerative Disorder of TMJ Treated With Autologous Bone Marrow-Derived Stem Cells Using Regentime® Procedure
Abstract: Temporomandibular joint (TMJ) disease is a type of degenerative musculoskeletal disorder that leads to morphological and functional abnormalities. It has a poorly understood progression with numerous independent and interrelated factors, which makes it difficult for the available treatment ... >> Read Article
Treatment of a chronic obstructive pulmonary disease case with Regentime® Procedure
Abstract: Chronic Obstructive Pulmonary Disease (COPD) is a common disease associated with high morbidity and mortality rates. It is characterized by airway and parenchymal inflammation leading to airway narrowing, decreased lung recoil, and eventual airflow limitation. Despite the advance in therap ... >> Read Article
Treatment of Long Standing Multiple Sclerosis with Regentime Stem Cell Technique
Abstract: This article is a case report in which we exposed the results of a multiple sclerosis (MS) patient, treated with stem cells. The 51 year old female patient was presenting with 23 year history of primary progressive type of MS. Her disease was physically debilitating causing numerous perman ... >> Read Article
Autologous Bone Marrow Derived Stem Cells for the Treatment of Multiple Sclerosis
Abstract: Stem cell therapy, an evolving, progressive field of therapeutics has shown several successes in areas where classic treatments failed to prevent or stop disability. Starting in 2009, twenty two sequential patients with progressive Multiple Sclerosis (MS) courses were treated with Autologo ... >> Read Article
Mesenchymal stem cell therapy for refractory scleroderma: a report of 2 cases
Abstract: We treated 2 patients with progressive, refractory scleroderma with a combined immunotherapy approach using plasmapheresis followed by rituximab and then intravenous umbilical-cord-derived allogeneic mesenchymal stem cells (MSCs). Both patients improved subjectively and objectively for ove ... >> Read ArticleConsultation
Call or write, and our consultant will give comprehensive answers to all your questions.
